Are you Dr. Tamaki?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
# A50
Cleveland, OH 44195Phone+1 216-444-5627Fax+1 216-445-7569
Summary
- Dr. Hiromichi Tamaki, MD is a rheumatologist in Cleveland, Ohio. He is currently licensed to practice medicine in Ohio.
Certifications & Licensure
OH State Medical License 2013 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- A feasible treatment strategy for tapering subcutaneous tocilizumab in giant cell arteritis: a 24-month multi-center retrospective study.Takanori Ito, Sho Fukui, Fumika N Nagase, Toshihiro Yamaguchi, Nobuhiro Oda
Rheumatology International. 2025-02-10 - 1 citationsTocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse Events.Fumika N Nagase, Sho Fukui, Naoho Takizawa, Toshihiro Yamaguchi, Nobuhiro Oda
The Journal of Rheumatology. 2024-12-01 - Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-center cross-sectional survey.Riki Kurokawa, Sachiko Ohde, Satoshi Kawaai, Hiromichi Tamaki
Modern Rheumatology. 2024-11-16
Press Mentions
Vasculitis Foundation Releases 2016 Vasculitis Foundation (VF) Research Funding ReportJanuary 12th, 2017
Professional Memberships
- Associate
- Member
